» Articles » PMID: 11961478

Modelling Valuations for Eq-5d Health States: an Alternative Model Using Differences in Valuations

Overview
Journal Med Care
Specialty Health Services
Date 2002 Apr 19
PMID 11961478
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The EQ-5D is a preference-based measure of health and is increasingly being used in the evaluation of health technologies. A 'tariff' of values for all 243 EQ-5D health states has been generated using direct valuations on a subset of these states. The tariff is used to express the value of differences between health states, and so this paper explores whether a tariff with better predictive ability can be calculated using differences between values rather than using the values themselves.

Methods: The original tariff (reported in this journal) was based on valuations for 42 EQ-5D states elicited from a representative sample of 2997 members of the UK general population using the time trade-off method. This same data are used to estimate a tariff based upon the differences in value between the worst possible state (33333) and all other states.

Results: A simple model that fits the data well is one in which the differences in value between 33333 and all other states are explained in terms of the change in each dimension plus a term to pick up whether some dimensions change by the maximum amount whereas others do not change at all. The mean absolute difference between the actual values and those predicted by this model is 0.03 (compared with 0.039 in the original model).

Conclusion: The model presented in this paper predicts the difference between 33333 and all other states remarkably well and can be used to generate a tariff for all EQ-5D health states. In fact, this model more accurately predicts the values of states for which there are direct observations, and so we recommend its comparison with the original model in evaluative studies.

Citing Articles

1-year data on patient-reported outcome is enough after surgery for degenerative cervical myelopathy: a cohort study from the Swedish Spine register.

Gerdhem L, MacDowall A, Gerdhem P Acta Orthop. 2025; 96():26-32.

PMID: 39786205 PMC: 11714782. DOI: 10.2340/17453674.2024.42630.


Quality of life, healthcare usage and finances of UK cancer survivors five years post-diagnosis: a matched controlled study.

Warrington L, Absolom K, Baxter P, Bojke C, Clarke G, Crossfield S J Cancer Surviv. 2024; .

PMID: 39627376 DOI: 10.1007/s11764-024-01708-x.


Association between physical activity and health-related quality of life among adults in China: the moderating role of age.

Hao H, Yuan Y, Li J, Zhao D, Li P, Sun J Front Public Health. 2024; 12:1334081.

PMID: 38601506 PMC: 11005473. DOI: 10.3389/fpubh.2024.1334081.


The IMPROVE trial: study protocol for a pragmatic cluster randomised controlled trial to assess the effectiveness of using lay health workers to improve uptake and completion of pulmonary rehabilitation in patients with chronic obstructive pulmonary....

Gilworth G, Harris K, Morgan T, Ayis S, Fox-Rushby J, Godfrey E Trials. 2024; 25(1):194.

PMID: 38500191 PMC: 10949634. DOI: 10.1186/s13063-024-07998-x.


Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial.

Royle K, Coulson A, Ramasamy K, Cairns D, Hockaday A, Quezada S BMJ Open. 2022; 12(11):e063037.

PMID: 36396306 PMC: 9677008. DOI: 10.1136/bmjopen-2022-063037.